Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04654260 · ClinicalTrials.gov registry record · NA

Behavior Therapy for Irritability in Autism

A NA study of Autism Spectrum Disorder and Aggression, sponsored by Yale University.

Active
Registry status
NA
Development phase
65
Enrollment target
1
Study location

NCT04654260 is a NA study of Autism Spectrum Disorder and Aggression that is active but no longer recruiting, run by Yale University. The registered enrollment target is 65 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04654260, a NA study of Autism Spectrum Disorder and Aggression, is active but no longer recruiting, sponsored by Yale University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
65 participants
Enrollment target
1
Study location

Study Summary

This is a clinical trial of a novel intervention, Behavioral Therapy for Irritability and Aggression (BTIA), for adolescents on the autism spectrum. The main goals of BTIA are to help adolescents develop emotion regulation skills to handle frustration and to strengthen skills for navigating the challenging and diverse experiences associated with the transition to adulthood. The study will test whether BTIA can be helpful to adolescents on the autism spectrum and to their families.

Interventions

  • BEHAVIORAL Behavioral Therapy for Irritability in Autism
  • BEHAVIORAL Psychoeducation and Supportive Therapy (PST)

Study Locations (1)

Connecticut

  • Yale Child Study Center - New Haven

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2020-12-10
Est. Completion 2026-02
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT04654260

The ClinicalTrials.gov registry entry for NCT04654260 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (52% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 2 interventions - of which Behavioral Therapy for Irritability in Autism is the first listed.

NCT04654260 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT04654260 about?

NCT04654260 is a clinical study titled "Behavior Therapy for Irritability in Autism". This is a clinical trial of a novel intervention, Behavioral Therapy for Irritability and Aggression (BTIA), for adolescents on the autism spectrum. The main goals of BTIA are to help adolescents develop emotion regulation skills to handle frustration and to strengthen skills for navigating the chal...

What is the current status of trial NCT04654260?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 65 participants. The study started on 2020-12-10. Estimated completion is 2026-02.

What conditions does trial NCT04654260 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder, Aggression, Anger, Asperger Syndrome, Pervasive Developmental Disorder.

What interventions are being tested in trial NCT04654260?

The interventions under investigation include: Behavioral Therapy for Irritability in Autism (BEHAVIORAL), Psychoeducation and Supportive Therapy (PST) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04654260?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04654260 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.